Relation of Lipid Profile with Ischemic Stroke

Authors

  • NOOR-UL-HUDA MARIA Department of Neurosurgery, Lahore General Hospital/ Punjab Institute of Neurosciences/ Postgraduate Medical Institute/Ameerudin Medical College, Lahore
  • Qurrat -ul-ain Department of Neurosurgery, Lahore General Hospital/ Punjab Institute of Neurosciences/ Postgraduate Medical Institute/Ameerudin Medical College, Lahore
  • Muhammad Anwar Department of Neurosurgery, Lahore General Hospital/ Punjab Institute of Neurosciences/ Postgraduate Medical Institute/Ameerudin Medical College, Lahore

Keywords:

Ischemic Stroke, Total cholesterol,, High density lipids, Triglycerides

Abstract

Objective: To evaluate correlation of blood total cholesterol (TC), high-density lipoprotein (HDL), triglycerides, and the TC:HDL ratio as risk factors for ischemic stroke.
Materials and Methods: After ethical approval from hospital ethical board this case control study was conducted in the department of neurosurgery and neurology Lahore General Hospital Lahore/Punjab Institute of Neurosciences/ Postgraduate Medical Institute/Ameerudin Medical College Lahore. Duration of study was two years from October 2015 to October 2017. A total of 600 patients were included in the study after obtaining written consent from patients. After completion of data collection, data was entered in computer software SPSS version 23 and analyzed for continuous and categorical variables. Continuous/numerical variables were presented as mean and SD and categorical variables were presented in form of numbers and percentages. Independent t-test and chi-square test were applied to see significance of data. P value less than or equal to 0.05 was considered as significant.
Results: Overall, 100% (n = 600) patients were included in this study. The study comprised of two equal groups, 50% (n = 300) in each, i.e. cases and controls. The controls had mean total cholesterol (TC), High-density lipoprotein (HDL) and triglycerides 220.76 ± 4.29 mg/dL, 54.02 ± 4.45 mg/dL and 153.99 ± 2.68 mg/dL res-pectively. The TC: HDL ratio was 5.48 ± 1.41 and 4.09 ± 1.22 for cases and controls respectively. The mean differences between total cholesterol (TC), High-density lipoprotein HDL, triglycerides and total cholesterol (TC): HCL ratios were statistically significant among both groups.
Conclusion: Results of our study revealed that significant difference was observed between cases and controls regarding the levels of Total cholesterol, HDL, triglycerides and TC:HDL ratio. Cases of ischemic stroke were found with high levels of TC, Tridlycerides, And TC:HDL ratio and low HDL , this difference was found statistically significant with P value 0.001. So it was concluded that hyperlipidemia has significant relation with ischemic stroke.

References

1. Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nat Rev Neurol. 2014; 10 (3): 135-143.
2. Tan CS, Müller-Riemenschneider F, Ng SH, Tan PZ, Chan BP, Tang KF et al. Trends in Stroke Incidence and 28-Day Case Fatality in a Nationwide Stroke Regi-stry of a Multiethnic Asian Population. Stroke, 2015; 46 (10): 2728-2734.
3. Kim BJ, Kim JS. Ischemic Stroke Subtype Classificat-ion: An Asian Viewpoint. J Stroke, 2014; 16 (1): 8-17.
4. Hashmi, M., Khan, M. &Wasay, M. Growing burden of stroke in Pakistan: a review of progress and limitations. Int. J. Stroke, 2013; 8: 575–581.
5. Weintraub H. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options. Atherosclerosis, 2013; 230 (2): 381-389.
6. Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM et al. The association between inflamma-tory markers, serum lipids and the risk of cardiovascu-lar events in patients with rheumatoid arthritis. Ann Rheum Dis. 2014; 73 (7): 1301-1308.
7. Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta-Analysis. Ann Neurol. 2013; 73: 38–47.
8. Scheitz JF, Seiffge DJ, Tütüncü S, Gensicke H, Aude-bert HJ, Bonati LH et al. Dose-Related Effects of Sta-tins on Symptomatic Intracerebral Hemorrhage and Outcome After Thrombolysis for Ischemic Stroke. Stroke, 2014; 45 (2): 509-514.
9. Woodward M, Huxley H, Lam TH, Barzi F, Lawes CM, Ueshima H et al. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil. 2005; 12 (5): 484-491.
10. Olson NC, Cushman M, Judd SE, Kissela BM, Safford MM, Howard G et al. Associations of coagulation fac-tors IX and XI levels with incident coronary heart dise-ase and ischemic stroke: the REGARDS study. J Thro-mb Haemost. 2017; 15: 1086–1094.
11. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K. Guidelines for prevention of stroke in pati-ents with ischemic stroke or transient ischemic attack.Stroke, 2006; 37 (2): 577-617.
12. Iso H, Jacobs DR, Wentworth D, et al. Serum Choleste-rol levels and six year mortality from stroke in 350977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989; 320: 904–909.
13. Leppala JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtypes. Stroke, 1999; 30: 2535–2540. 26.
14. Koren-Morag N, Tanne D, Graff E, et al. Low and high-density lipoprotein cholesterol and ischemic cere-brovascular disease. Arch Intern Med. 2002; 162: 993–999.
15. Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke. Stroke, 2003; 34: 623–631.
16. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cho-lesterol, total cholesterol, and the risk of stroke in mid-dle-aged British men. Stroke, 2000; 31: 1882–1888.
17. Sacco RL, Benson RT, Kargman DE, et al. High-den-sity lipoprotein cholesterol and ischemic stroke in the elderly. JAMA. 2001; 285: 2729–2735.
18. Downs JR, Clearfield M, Weis S, et al. Primary preven-tion of acute coronary events with Lovastatin in men and women with average cho- lesterol levels: the results of AFCAPS/TEXCAPS. JAMA. 1998; 279: 16 15–1622.
19. Shepherd J, Cobbe SM, Ford I, et al. Prevention of cor-onary disease with pravastatin in men with hypercho-lesterolemia. N Engl J Med. 1995; 333: 1301–1307.
20. Sacks F, Pfeffer MA, Moye LA, et al. The effect of pra-vastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996; 335: 1001–1009.
21. Kinosian B, Glick H, Garland G. Cholesterol and coro-nary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994; 121: 641–647.

Downloads

Published

2018-06-30

Issue

Section

Original Articles